Dr. Donington is a Professor in Surgery and chief of the section of Thoracic Surgery. Her clinical and interests focus on the diagnosis and treatment of non-small cell lung cancer. Areas of expertise include the use of multimodality therapy for locally advanced lung cancer, treatment options for high-risk patients with early stage lung cancer and lung cancer in women. She is the surgical chair for the thoracic malignancy group of NRG Oncology Group, council member for the Western Thoracic Surgical Association, and immediate past-president of the New York Society for Thoracic Surgery, and the Women in Thoracic Surgery.
NYU
New York, NY
MS - Clinical Research
2010
Mayo Hospital and Clinics
Rochester, MN
- Cardiothoracic Surgery
2002
Georgetown University
Washington, DC
- General Surgery
1999
NIH/NCI/Surgery Branch
Bethesda, MD
- Surgical Oncology
1996
Rush University
Chicago, IL
MD - Medicine
1992
University of Michigan
Ann Arbor, MI
BS - Biology
1987
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2023 01; 7:e2200273.
PMID: 36603171
Impact of Federal Lung Cancer Screening Policy on the Incidence of Early-stage Lung Cancer.
Impact of Federal Lung Cancer Screening Policy on the Incidence of Early-stage Lung Cancer. Ann Thorac Surg. 2022 Dec 05.
PMID: 36470567
Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer.
Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2022 Nov 04.
PMID: 36528434
Lung resection surgery in Jehovah's Witness patients: a 20-year single-center experience.
Lung resection surgery in Jehovah's Witness patients: a 20-year single-center experience. J Cardiothorac Surg. 2022 Oct 20; 17(1):272.
PMID: 36266727
Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon.
Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. Ann Thorac Surg. 2022 Sep 27.
PMID: 36174774
Postoperative complications of thymectomy in myasthenia gravis: does steroid use play a role?
Postoperative complications of thymectomy in myasthenia gravis: does steroid use play a role? Ann Thorac Surg. 2022 Aug 22.
PMID: 36007565
Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC.
Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC. JTO Clin Res Rep. 2022 Aug; 3(8):100363.
PMID: 36046399
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy.
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy. J Thorac Oncol. 2022 09; 17(9):1130-1136.
PMID: 35788405
The Effect of Normothermic Machine Perfusion on the Immune Profile of Donor Liver.
The Effect of Normothermic Machine Perfusion on the Immune Profile of Donor Liver. Front Immunol. 2022; 13:788935.
PMID: 35720395
Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care.
Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care. Ann Surg Oncol. 2022 09; 29(9):5344-5346.
PMID: 35622177